Glenmark Pharmaceuticals Ltd Quarterly Results
Q1 FY25-26 Results Summary
Revenue
The revenue stands at ₹3,264.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.25 per cent from ₹3,256.20 crore. This corresponds to a year-on-year *(YoY) growth of 0.62 per cent.
Operating Profit
Operating Profit stands at ₹84.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.00 per cent from ₹78.40 crore. This corresponds to a year-on-year *(YoY) growth of 19.14 per cent.
PBDT
PBDT stands at ₹178.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 38.61 per cent from ₹128.80 crore. This corresponds to a year-on-year *(YoY) decline of 25.58 per cent.
Profit Before Tax
Profit Before Tax stands at ₹95.57 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,099.12 per cent from ₹7.97 crore. This corresponds to a year-on-year *(YoY) decline of 79.33 per cent.
Net Profit
Net Profit stands at ₹370.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.95 per cent from ₹377.47 crore. This represents a 8.77 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Glenmark Pharmaceuticals Ltd News
Glenmark Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Glenmark Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Glenmark Pharmaceuticals Ltd Research Reports
Glenmark Pharmaceuticals Ltd Financial Reports
Glenmark Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Glenmark Pharma. | -1.26% | 1.89% | -1.80% | 8.75% | -7.93% | 40.57% |
| Aurobindo Pharma | -0.92% | -0.63% | -5.49% | 3.50% | 0.50% | -3.59% |
| Biocon | -1.68% | -0.04% | -6.11% | 1.83% | -5.42% | -1.01% |
| Abbott India | 0.47% | 2.26% | -3.75% | -6.55% | -15.38% | 4.89% |
| Laurus Labs | 1.21% | -1.72% | -5.99% | 8.14% | 14.45% | 90.09% |
| Glaxosmi. Pharma | -3.32% | 1.84% | -6.67% | -13.96% | -25.17% | 12.05% |
| Ipca Labs. | -1.53% | -1.50% | 2.04% | 12.68% | -1.38% | 1.41% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Glenn Saldanha
ED / WTD / Promoter : Cheryl Pinto
ED / President / Global CFO : Anurag Mantri
Non Executive Director : B E Saldanha
Independent Non Exe. Director : Sona Saira Ramasastry
Independent Non Exe. Director : Dipankar Bhattacharjee
Independent Non Exe. Director : V R Iyer
Independent Non Exe. Director : Pradeep Kumar Sinha
Company Sec. & Compli. Officer : Harish Kuber